The Lancet: Excellent Efficacy of Hisun’s Favipiravir Against COVID-19 in Turkey
TAIZHOU, China,
Aug. 26, 2020
/PRNewswire/
Recently, Preprints with The Lancet
has published a preliminary study report on Turkey’s using Favipiravir produced by Hisun to treat COVID-19.
The report
says after Favipiravir was used in hospitals across Turkey for five days,
the overall ICU patient admission rate in the country
was reduced by half and that for patients under 60 years old dropped from nearly 20% to 6.6%, with a significant decline in the intubation rate
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3622357
Nachricht | finanzen.net